|
|
|
|
LEADER |
00000cam a2200000Mu 4500 |
001 |
EBOOKCENTRAL_ocn469589848 |
003 |
OCoLC |
005 |
20240329122006.0 |
006 |
m o d |
007 |
cr mn|---||||| |
008 |
091116s2005 vtu ob 001 0 eng d |
040 |
|
|
|a MERUC
|b eng
|e pn
|c MERUC
|d EBLCP
|d OCLCQ
|d IDEBK
|d OCLCQ
|d UKDOC
|d OCLCQ
|d DEBSZ
|d TULIB
|d OCLCQ
|d ZCU
|d OCLCQ
|d MERUC
|d U3W
|d OCLCO
|d OCLCQ
|d OCLCF
|d OCLCO
|d STF
|d OCLCA
|d ICG
|d OCLCQ
|d TKN
|d DKC
|d UMR
|d AU@
|d OCLCQ
|d OCL
|d OCLCQ
|d OCLCO
|d OCLCQ
|d OCLCO
|d OCLCL
|
019 |
|
|
|a 476059240
|a 779916221
|
020 |
|
|
|a 9780080492513
|q (electronic bk.)
|
020 |
|
|
|a 0080492517
|q (electronic bk.)
|
029 |
1 |
|
|a AU@
|b 000048757305
|
029 |
1 |
|
|a AU@
|b 000051553922
|
029 |
1 |
|
|a DEBBG
|b BV044124255
|
029 |
1 |
|
|a DEBSZ
|b 430399928
|
035 |
|
|
|a (OCoLC)469589848
|z (OCoLC)476059240
|z (OCoLC)779916221
|
050 |
|
4 |
|a HD9999.B44
|a HD9999.B442 B542 2005
|a HD9999.B442B542 2005
|a HD9999.B442
|
082 |
0 |
4 |
|a 174.96606
|a 174/.96606 22
|
049 |
|
|
|a UAMI
|
100 |
1 |
|
|a Finegold, David L.
|
245 |
1 |
0 |
|a BioIndustry Ethics.
|
260 |
|
|
|a Burlington :
|b Elsevier,
|c 2005.
|
300 |
|
|
|a 1 online resource (384 pages)
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
505 |
0 |
|
|a BIOINDUSTRY ETHICS; BIOINDUSTRY ETHICS; Contents; Research Team; Preface; Acknowledgments; Introduction; Merck: Staying the Course; Genzyme: Putting Patients First; Millennium pharmaceuticals, Inc.: Creating and Sustaining Corporate Values; Maxim Pharmaceuticals (A): Internal and External Dialogues; Diversa Inc.: Ethical Issues in Bioprospecting Partnerships; Pipeline Biotech A/S: Competing Regulatory Regimes for Laboratory Animal Experiments; TGN Biotech: A Start-Up with Ethical Roots; Interleukin Genetics and Alticor: An Unlikely Partnership.
|
505 |
8 |
|
|a Sciona Ltd.: A Pioneer in Nutrigenomics: The Path to Consumer AcceptanceAffymetrix, Inc.: Using Corporate Ethics Advice; PharmaSNPs Inc.: Creating an Ethics Advisory Board; Monsanto Company: Bio- Agriculture Pioneer; Novo Nordisk: The Triple Bottom Line; Conclusion: Lessons for Companies and Future Issues; Index.
|
520 |
|
|
|a An introduction to the increasingly important role of ethics in bioscience companies.
|
588 |
0 |
|
|a Print version record.
|
504 |
|
|
|a Includes bibliographical references and index.
|
590 |
|
|
|a ProQuest Ebook Central
|b Ebook Central Academic Complete
|
650 |
|
0 |
|a Biotechnology industries
|x Moral and ethical aspects
|v Case studies.
|
650 |
|
0 |
|a Business ethics
|x Moral and ethical aspects
|v Case studies.
|
650 |
|
0 |
|a Pharmaceutical industry
|x Moral and ethical aspects
|v Case studies.
|
650 |
|
6 |
|a Bio-industries
|x Aspect moral
|v Études de cas.
|
650 |
|
6 |
|a Morale des affaires
|x Aspect moral
|v Études de cas.
|
650 |
|
6 |
|a Industrie pharmaceutique
|x Aspect moral
|v Études de cas.
|
650 |
|
7 |
|a Biotechnology industries
|x Moral and ethical aspects
|2 fast
|
650 |
|
7 |
|a Pharmaceutical industry
|x Moral and ethical aspects
|2 fast
|
655 |
|
7 |
|a Case studies
|2 fast
|
700 |
1 |
|
|a Bensimon, Cecile M.
|
700 |
1 |
|
|a Daar, A. S.
|
700 |
1 |
|
|a Eaton, Margaret L.
|
700 |
1 |
|
|a Godard, Béatrice.
|
700 |
1 |
|
|a Knoppers, Bartha Maria.
|
700 |
1 |
|
|a Mackie, Jocelyn.
|
700 |
1 |
|
|a Singer, Peter A.,
|d 1960-
|
758 |
|
|
|i has work:
|a Bioindustry ethics (Text)
|1 https://id.oclc.org/worldcat/entity/E39PCFv7TKhpcVRk6J8fmt3TVC
|4 https://id.oclc.org/worldcat/ontology/hasWork
|
776 |
1 |
|
|z 9780123693709
|
856 |
4 |
0 |
|u https://ebookcentral.uam.elogim.com/lib/uam-ebooks/detail.action?docID=294538
|z Texto completo
|
938 |
|
|
|a 123Library
|b 123L
|n 44578
|
938 |
|
|
|a ProQuest Ebook Central
|b EBLB
|n EBL294538
|
938 |
|
|
|a ProQuest MyiLibrary Digital eBook Collection
|b IDEB
|n 100533
|
994 |
|
|
|a 92
|b IZTAP
|